Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum

The Journal of Comparative Neurology
M WatanabeY Inoue

Abstract

The distribution of five NMDA receptor channel subunit mRNAs was examined in the mouse cerebellum from embryonic day 13 through postnatal day 56, by in situ hybridization with subunit-specific oligonucleotide probes. At postnatal days 21 and 56, each cerebellar neuron displayed differential expressions of the epsilon subunit mRNAs. The granule cells showed hybridizing signals for the epsilon 1 and epsilon 3 subunit mRNAs, the molecular layer neurons for the epsilon 4 subunit mRNA, and the cerebellar nucleus neurons for the epsilon 1 and epsilon 4 subunit mRNAs, whereas the Purkinje cells did not express any epsilon subunit mRNAs. At early postmitotic stages of development, the epsilon 2 subunit mRNA appeared in each cerebellar neuron, including the Purkinje cells, and the epsilon 4 subunit mRNA appeared in neurons of the molecular layer and the cerebellar nuclei. The expression patterns in the cerebellum altered drastically during the first 2 postnatal weeks; the epsilon 1 and epsilon 3 subunit mRNAs appeared in the granule cells and the cerebellar nucleus neurons, whereas the epsilon 2 subunit mRNA disappeared from each neuron and the signal levels of the epsilon 4 subunit mRNA decreased remarkably. In contrast to the differen...Continue Reading

References

Nov 1, 1992·Journal of Neurophysiology·C RosenmundG L Westbrook
Jul 2, 1992·Nature·T KutsuwadaM Arakawa
Aug 1, 1992·Journal of Neurochemistry·J A BeatonD T Monaghan
Mar 23, 1992·FEBS Letters·M YamazakiM Mishina
Feb 26, 1991·European Journal of Pharmacology·D T Monaghan, J A Beaton
Jun 22, 1991·Proceedings. Biological Sciences·M Farrant, S G Cull-Candy
May 1, 1991·Journal of Neurochemistry·I J Reynolds, A M Palmer
Nov 7, 1991·Nature·K MoriyoshiS Nakanishi
Aug 22, 1990·Proceedings. Biological Sciences·D J PerkelR A Nicoll
Apr 1, 1990·Journal of Neurochemistry·M L QuarumE Weber
Dec 15, 1989·Neuroscience Letters·J Garthwaite, P S Beaumont
Jan 1, 1987·Progress in Neurobiology·M L Mayer, G L Westbrook
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·T Hirano, S Hagiwara
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D T MonaghanC W Cotman
May 22, 1994·The Journal of Comparative Neurology·M WatanabeY Inoue
Dec 15, 1993·The Journal of Comparative Neurology·M WatanabeM Mishina

❮ Previous
Next ❯

Citations

Jun 14, 1996·Brain Research. Developmental Brain Research·M Barrios, S Liljequist
Apr 1, 1995·Brain Research. Molecular Brain Research·J M LuqueJ G Richards
Oct 1, 1995·Brain Research. Molecular Brain Research·K IkedaM Mishina
Feb 1, 1996·Brain Research. Molecular Brain Research·M NagasawaM Mishina
Jul 1, 1996·Brain Research. Molecular Brain Research·V V KoltchineS N Treistman
Apr 5, 2005·Brain Research. Developmental Brain Research·Friedrich MetzgerUlrich L M Eisel
Oct 15, 2013·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Elham TavassoliAli Kalantari Hesari
Jul 2, 2003·Experimental and Molecular Pathology·Hirotake TakaiKunio Doi
Feb 1, 1997·Brain Research. Molecular Brain Research·S UchinoM Mishina
Sep 16, 2003·Neurochemistry International·Takahiro KitanoSeiji Ito
Aug 28, 1999·Progress in Neurobiology·T Yamakura, K Shimoji
Mar 18, 2000·Toxicology Letters·F Fonnum, E A Lock
Aug 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kouichirou IijimaShigetada Nakanishi
Aug 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Claire MeissirelPeter Carmeliet
Jan 15, 1997·Annals of the New York Academy of Sciences·K W Nordeen
Dec 16, 2011·The Journal of Pharmacology and Experimental Therapeutics·Xueliang FanEllen J Hess
Aug 19, 2010·Pharmacological Reviews·Stephen F TraynelisRay Dingledine
May 20, 1999·Annual Review of Pharmacology and Toxicology·S J MyersK Borges
Nov 17, 2007·Journal of Neurochemistry·Krisztián TárnokKatalin Schlett
Jul 1, 2004·Journal of Child Neurology·Timothy A SimeoneJong M Rho
Jul 25, 2006·Cell and Tissue Research·Georg Köhr
Jul 13, 2006·Psychopharmacology·Janel M Boyce-Rustay, Andrew Holmes
Oct 24, 2007·The European Journal of Neuroscience·Tadashi Yamazaki, Shigeru Tanaka
Mar 8, 2008·The Tohoku Journal of Experimental Medicine·Masahiko Watanabe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.